BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9390203)

  • 1. The antitumor effects of levamisole in mice are mediated by NC-1.1+ cells.
    Clarke GR; Burton RC; Smart YC
    Cancer Immunol Immunother; 1997 Oct; 45(2):115-8. PubMed ID: 9390203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic T-cell-mediated antitumor effect of levamisole against murine syngeneic fibrosarcoma.
    Gomi K; Morimoto M; Nomoto K
    Cancer Res; 1982 Oct; 42(10):4197-202. PubMed ID: 6980702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural cytotoxicity of NC-2+ cells against the growth and metastasis of WEHI-164 fibrosarcoma.
    Shirzad H; Burton RC; Smart YC; Rafieian-kopaei M; Shirzad M
    Scand J Immunol; 2011 Feb; 73(2):85-90. PubMed ID: 21198748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combination 5-fluorouracil/levamisole induces enhanced rat Kupffer cell-mediated cytotoxicity in vitro against the syngeneic colon adenocarcinoma cell line CC531.
    Schuurman B; Sirovich I; Heuff G; van der Wilt CL; Peters GJ; Beelen RH; Meyer S
    J Surg Oncol; 1995 Nov; 60(3):180-4. PubMed ID: 7475068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration by levamisole of immune responses suppressed in tumor-bearing mice.
    Shiraishi M; Himeno K; Nomoto K
    Cancer Immunol Immunother; 1983; 15(2):121-5. PubMed ID: 6553512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of growth of tumours in NC-cell-depleted mice with NC- and NK-cell-mediated lysis in vitro.
    Smart YC; Farrelly ML; Burton RC
    Int J Cancer; 1992 Mar; 50(5):817-21. PubMed ID: 1544715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody anti-NC-2 identifies a second receptor on cells mediating natural cytotoxicity in mice.
    Shirzadeh H; Burton RC; Brien JH; Smart YC
    Immunology; 1998 Jan; 93(1):122-8. PubMed ID: 9536128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNF-alpha is not the sole mediator of WEHI-164 tumour cell killing in natural cytotoxicity.
    Clarke GR; Shirzadeh H; Pang G; Beagley KW; Burton RC; Smart YC
    Cytokine; 1997 Apr; 9(4):254-62. PubMed ID: 9112334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ly-6C+ natural T (NT) cells mediate immune surveillance against NK-sensitive and NK-resistant transplantable tumours in certain strains of mice.
    Martiniello R; Burton RC; Smart YC
    Int J Cancer; 1996 May; 66(4):532-7. PubMed ID: 8635870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of surgical removal and effect of levamisole on cytotoxic T-cell-mediated antitumor immunity in mice.
    Gomi K; Morimoto M; Nomoto K
    Cancer Res; 1983 Nov; 43(11):5120-5. PubMed ID: 6604572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of levamisole (NSC-177023) and tetramisole (NSC-102063) in experimental tumor systems.
    Johnson RK; Houchens DP; Gaston MR; Goldin A
    Cancer Chemother Rep; 1975; 59(4):697-705. PubMed ID: 1175164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Problems and challenges in the use of immunomodulating agents. A general introduction.
    Spreafico F
    Int Arch Allergy Appl Immunol; 1985; 76 Suppl 1():108-18. PubMed ID: 3884519
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of levamisole on methylcholanthrene-induced tumor. II. Potentiation of cytotoxic T-cell activities].
    Gomi K; Morimoto M; Nomoto K
    Gan To Kagaku Ryoho; 1982 Jul; 9(7):1269-76. PubMed ID: 6985196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemo-immunotherapy of murine tumors using interleukin-2 (IL-2) and cyclophosphamide. IL-2 can facilitate or inhibit tumor growth depending on the sequence of treatment and the tumor type.
    Kedar E; Ben-Aziz R; Epstein E; Leshem B
    Cancer Immunol Immunother; 1989; 29(1):74-8. PubMed ID: 2785003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic antitumor effects of topoisomerase inhibitors and natural cell-mediated cytotoxicity.
    Utsugi T; Demuth S; Hanna N
    Cancer Res; 1989 Mar; 49(6):1429-33. PubMed ID: 2538225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoration of immune response by levamisole in B-77 virus induced tumor-bearing rats.
    Kalafut F; Kusenda J; Novotná L; Klobusická M
    Neoplasma; 1988; 35(4):369-78. PubMed ID: 2847064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
    Colmenares C; Lopez C
    J Immunol; 1986 May; 136(9):3473-80. PubMed ID: 2420891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunobiology of primary intracranial tumors. Part 4: levamisole as an immune stimulant in patients and in the ASV glioma model.
    Mahaley MS; Steinbok P; Aronin P; Dudka L; Zinn D
    J Neurosurg; 1981 Feb; 54(2):220-7. PubMed ID: 6256510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural cytotoxic activity in a cloned natural killer cell line is mediated by tumor necrosis factor.
    Richards AL; Dennert G; Pluznik DH; Takagaki Y; Djeu JY
    Nat Immun Cell Growth Regul; 1989; 8(2):76-88. PubMed ID: 2761550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levamisole: might it be used in treatment and prevention of atopic diseases?
    Kocabas CN; Sekerel BE; Firat PA; Okur H; Adahoglu G
    J Asthma; 2004 Aug; 41(5):547-51. PubMed ID: 15360063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.